We would like to show you a description here but the site won’t allow us.

Oct 17, 2017 · This study has comprehensively evaluated technical, practical and study design considerations for potential protein biomarker detection using the currently available technologies.

Interestingly, the same group of investigators further showed LILRB1 as a biomarker for CD19-B-ALL in post-CD19 directed therapy relapsed disease [12], high-lighting the utility of LILRB1 in MRD detection.

Our study suggests that KMT2A/C mutations function as a novel and potential predictive biomarker for ICI treatment in multiple solid tumors and the underlying mechanism is worth investigating.

Correction: Biomarker Research (2024) 12:54 https://doi.org/10.1186/s40364-024-00602-z The authors wish to note Ruirui Jing as a co-Corre-sponding Author of the original article; the attribution of which …

SOX11 expression was detected in most cyclin D1- negative MCL and can serve as a specific biomarker for the diagnosis of this subset of MCL. Lack of SOX11 expression in MCL was associated with an …

Biomarker analysis via ctDNA in the baseline suggested concomitant mutations from multiple path-ways in HER2-related signaling network may be a poten-tial eficacy and prognosis biomarker for pyrotinib …

Another study also indicated the potential of its composition as a biomarker. Patients with abundant Prevotella 9 had significantly shorter OS, and those with abundant Lachnoclostridium presented …

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies Ugo Testa1*, Elvira Pelosi1 and Arthur Frankel2 Abstract

A biomarker is a measurable substance or characteristic in an organism that can indicate the presence or sever-ity of a disease, infection, or other physiological state [1].